Skip to main content

Table 4 Drugs used to treat influenza-like illness (ILI) from pH1N1 influenza, before sARI onset in 50 severe acute respiratory infection (sARI) cases and during equivalent period after ILI onset in 79 controls

From: Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study

DrugsNumber exposedPercent exposedMatched odds ratioa (95%CI)
Case (N = 50)Control (N = 79)CaseControl
Glucocorticosteroidsb before sARI onset17334.03.817.0(2.1–135.0)
Glucocorticosteroidsb before both pneumonia and SARI15230.02.515.0(1.9–120.9)
Pyrazolonesc13526.06.33.0(0.8–11.7)
Neuraminidase inhibitor468.07.60.6(0.1–3.4)
Amantidine346.05.10.3(0.0–2.8)
Ribavirin213242.0411.3(0.5–3.2)
Other antivirals61138.861.20.5(0.1–2.5)
Antibiotics436386.079.70.8(0.2–2.6)
Acetaminophen141228.015.2
Ibuprofen111522.019.00.8(0.2–2.8)
Nimesulide91518.019.01.4(0.4–4.4)
Traditional Chinese medicine285156.064.61.6(0.7–3.4)
  1. aOdds Ratio is matched by age group and underlying disease, bdexamethasone or methyl prednisolone, caminopyrine or dipyrone